Substipharm
Develops and supplies medicines and vaccines for pharmaceutical partners and patients worldwide
Highlights
- New on EvolcAdded 2026-10-28
About Substipharm
Substipharm develops pharmaceutical dossiers and supplies finished medicines and vaccines. Its portfolio includes branded specialties, generics and vaccines against Japanese encephalitis and enterovirus A71.
The company licenses pharmaceutical dossiers and commercializes its own products directly or through partners. It operates in over 100 countries, with a direct presence in Europe and Southeast Asia.
Substipharm is headquartered in Paris and has offices in London and Milan. The business began in 1995, and the current legal entity was founded in 2004.
Product: Pharmaceutical dossiers, branded and generic medicines, and vaccines.
Public tenders won
4 tenders won since 1 Jan 2024 from 4 public buyers in Germany, France, worth €164.4M as awarded. From EU award notices (TED) that name Substipharm by its registry number.
- 13 Aug 2025 IKK classic · Arzneimittelausschreibung 2025_vergebene Aufträge · €162.3M notice
- 16 May 2025 GCS GRAPS GRAND EST · Fourniture de spécialités pharmaceutiques au profit des adhérents du GCS GRAPS Grand Est notice
- 16 Jan 2025 GCS HACOM · 24-10 ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2024 · €2.1M notice
- 22 Mar 2024 Centre Hospitalier de l'Agglomération de Nevers · Fourniture de spécialités pharmaceutiques : Médicaments (83 lots) notice
Jobs at Substipharm
Leadership
- Léopold Berthier · Chief Executive OfficerSource: company website
More biotech & pharma companies
Tedis
Pharmaceutical wholesale distributor linking laboratories with pharmacies and hospitals in France and export markets in Africa and AsiaNew on EvolcSalary transparentThea Open Innovation
Ophthalmology innovation partnerships and investment for startups, researchers and companies developing eye-care treatmentsNew on EvolcTissium
Biomorphic programmable polymers for tissue reconstruction in surgery, developed for medtech and surgical useNew on EvolcUPSA
French pharmaceutical laboratory making self-medication drugs, dietary supplements and medical devices for patients and pharmacistsUrosphere
Preclinical research models and drug-development services for pharmaceutical and biotechnology researchersNew on EvolcValerio Therapeutics
Develops precision-targeted antibody therapies for complex and underserved diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Elementor
- Google reCAPTCHA
- Matomo
- PHP
- WordPress
- jQuery
